The doses used in animal studies, when adjusted for body weight, may not correspond to the human dose in the supplement
The paper notes 503A compounding pharmacies are only permitted to compound for an identified individual person and cannot produce products that are copies of commercially available medicine
Andrew Hill, Department of Pharmacology and Therapeutics, University of Liverpool, United Kingdom, supervising author of the study, commented, Worldwide, more people are dying from diabetes and clinical obesity than HIV, tuberculosis, and malaria combined now
The fabrication of nanoparticles employs proteins such as BSA and HAS
References: Pickart, Loren, and Anna Margolina
As research continues to uncover these diverse benefits, the role of GLP-1 agonists in medicine could expand significantly, offering new hope for patients with a variety of health conditions